Type 1 diabetes mellitus patients with high BMI and hypoglycemia may improve quality of life through dapagliflozin treatment.
Read More »Diabetes and Its Contributions to Early COVID-19 Outcomes
Patients with diabetes and COVID-19 were more likely to die within 14 days of hospitalization than those without diabetes.
Read More »Antibiotic Treatment Increases Risk for Type 1 Diabetes
Both prenatal and first year of life antibiotic exposure may increase the risk for developing type 1 diabetes in childhood.
Read More »Metabolic Syndrome and Complication Risk in Type 1 Diabetes
Researchers sought to identify the prevalence of metabolic syndrome in patients with type 1 diabetes and its relationship to diabetic complication development.
Read More »How to Eliminate Carb Counting for Type 1 Pump Users
Could adding a SGLT-2 inhibitor to a closed-loop automated insulin delivery reduce the need for carbohydrate counting?
Read More »Type 1 Diabetes and Cardiovascular Disease
Type 1 diabetes increases the risk of premature death from cardiovascular disease.
Read More »The Effect Of COVID-19 on Children with Type 1 Diabetes
Study found children with a new diagnosis of type 1 diabetes experienced higher rates of diabetic ketoacidosis in the COVID-19 pandemic.
Read More »High-Intensity Interval Training and Type 1 Diabetes: Effect on Glycemic Control
Does a 12-week high-intensity interval training (HIIT) program show superior glucose control in type 1 diabetes than other forms of exercise?
Read More »Oral Health and Diabetes Complications
Better oral health may be linked to better outcomes in patients with diabetes, but which comes first -- gum disease or diabetes?
Read More »Using Glucagon-like Peptide 1 Receptor Agonists In Type 1 Diabetes
Examining the effects of GLP-1RAs exenatide and liraglutide on weight and insulin dosage for type 1 diabetes patients.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.